ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 78 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $603,083 | +123736.3% | 840,651 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $487 | -99.9% | 840,651 | -10.7% | 0.00% | -33.3% |
| Q3 2022 | $895,000 | -20.8% | 941,751 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $1,130,000 | -13.1% | 941,751 | -5.1% | 0.00% | 0.0% |
| Q1 2022 | $1,300,000 | +68.0% | 992,729 | +125.8% | 0.00% | +100.0% |
| Q4 2021 | $774,000 | -75.7% | 439,574 | -70.0% | 0.00% | -80.0% |
| Q3 2021 | $3,183,000 | -44.1% | 1,466,807 | -9.8% | 0.01% | -47.4% |
| Q2 2021 | $5,693,000 | +2262.2% | 1,626,698 | +7228.1% | 0.02% | +1800.0% |
| Q4 2020 | $241,000 | -91.4% | 22,198 | -91.9% | 0.00% | -93.8% |
| Q3 2020 | $2,814,000 | -57.9% | 273,201 | -14.7% | 0.02% | -62.8% |
| Q2 2020 | $6,686,000 | +2009.1% | 320,215 | +218.4% | 0.04% | +975.0% |
| Q4 2018 | $317,000 | – | 100,558 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |